Study Results from University of Virginia in the Area of Human Immunodeficiency Virus Reported (Affordable Care Act Qualified Health Plan Coverage:…

Study Results from University of Virginia in the Area of Human Immunodeficiency Virus Reported (Affordable Care Act Qualified Health Plan Coverage: Association With Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a ...)

By a News Reporter-Staff News Editor at Insurance Weekly News -- Investigators publish new report on Human Immunodeficiency Virus. According to news reporting from Charlottesville, Virginia, by VerticalNews journalists, research stated, "With the Patient Protection and Affordable Care Act, many state AIDS Drug Assistance Programs (ADAPs) shifted their healthcare delivery model from direct medication provision to purchasing qualified health plans (QHPs). The objective of this study was to characterize the demographic and healthcare delivery factors associated with Virginia ADAP clients' QHP enrollment and to assess the relationship between QHP coverage and human immunodeficiency virus (HIV) viral suppression."

Funders for this research include Agency for Healthcare Research and Quality, National Institute of Allergy and Infectious Diseases.

The news correspondents obtained a quote from the research from the University of Virginia, "The cohort included persons living with HIV who were enrolled in the Virginia ADAP (n = 3933). Data were collected from 1 January 2013 through 31 December 2014. Multivariable binary logistic regression was conducted to assess for associations with QHP enrollment and between QHP coverage and viral load (VL) suppression. In the cohort, 47.1% enrolled in QHPs, and enrollment varied significantly based on demographic and healthcare delivery factors. In multivariable binary logistic regression, controlling for time, age, sex, race/ethnicity, and region, factors significantly associated with achieving HIV viral suppression included QHP coverage (adjusted odds ratio, 1.346; 95% confidence interval, 1.041-1.740; P=.02), an initially undetectable VL (2.809; 2.174-3.636; P<.001), HIV rather than AIDS disease status (1.377; 1.049-1.808; P=.02), and HIV clinic (P <.001). QHP coverage was associated with viral suppression, an essential outcome for individuals and for public health."

According to the news reporters, the research concluded: "Promoting QHP coverage in clinics that provide care to persons living with HIV may offer a new opportunity to increase rates of viral suppression."

For more information on this research see: Affordable Care Act Qualified Health Plan Coverage: Association With Improved HIV Viral Suppression for AIDS Drug Assistance Program Clients in a Medicaid Nonexpansion State. Clinical Infectious Diseases, 2016;63(3):396-403. Clinical Infectious Diseases can be contacted at: Oxford Univ Press Inc, Journals Dept, 2001 Evans Rd, Cary, NC 27513, USA. (Oxford University Press - www.oup.com/; Clinical Infectious Diseases - cid.oxfordjournals.org)

Our news journalists report that additional information may be obtained by contacting of Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA 22908, United States. Additional authors for this research include A. Rhodes, S. Bailey, L. Yerkes, C.L. Engelhard, K.S. Ingersoll, G.J. Stukenborg and R. Dillingham.

Keywords for this news article include: Charlottesville, Virginia, United States, North and Central America, Managed Care, Drugs and Therapies, Epidemiology, Immune System Diseases and Conditions, Viral Sexually Transmitted Diseases, Human Immunodeficiency Virus, Primate Lentiviruses, Affordable Care Act, Vertebrate Viruses, HIV Infections, Health Policy, Retroviridae, RNA Viruses, Medicaid, HIV/AIDS, University of Virginia.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC